Cargando…
Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies. Many recent studies focused on the interaction between α-synuclein (α-syn) and dopamine in the pathogenesis of PD, and fluorescent anisotropy sug...
Autores principales: | Nakaso, Kazuhiro, Tajima, Naoko, Ito, Satoru, Teraoka, Mari, Yamashita, Atsushi, Horikoshi, Yosuke, Kikuchi, Daisuke, Mochida, Shinsuke, Nakashima, Kenji, Matsura, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573015/ https://www.ncbi.nlm.nih.gov/pubmed/23457458 http://dx.doi.org/10.1371/journal.pone.0055068 |
Ejemplares similares
-
Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells
por: Teraoka, Mari, et al.
Publicado: (2012) -
Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
por: Calogero, Alessandra Maria, et al.
Publicado: (2023) -
The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding
por: Pham, Chi L. L., et al.
Publicado: (2013) -
Tuning the Balance between Fibrillation and Oligomerization of α-Synuclein
in the Presence of Dopamine
por: Saha, Shivnetra, et al.
Publicado: (2018) -
Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)